- Home
- SANW vs BRTX Comparison
SANW vs BRTX Comparison
Compare SANW & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- BRTX
- Stock Information
- Founded
- SANW 1980
- BRTX 1997
- Country
- SANW United States
- BRTX United States
- Employees
- SANW N/A
- BRTX N/A
- Industry
- SANW Farming/Seeds/Milling
- BRTX Managed Health Care
- Sector
- SANW Consumer Staples
- BRTX Health Care
- Exchange
- SANW Nasdaq
- BRTX Nasdaq
- Market Cap
- SANW 18.8M
- BRTX 15.9M
- IPO Year
- SANW 2010
- BRTX N/A
- Fundamental
- Price
- SANW $7.50
- BRTX $1.80
- Analyst Decision
- SANW Strong Buy
- BRTX Strong Buy
- Analyst Count
- SANW 1
- BRTX 1
- Target Price
- SANW $35.00
- BRTX $18.00
- AVG Volume (30 Days)
- SANW 8.3K
- BRTX 812.7K
- Earning Date
- SANW 02-13-2025
- BRTX 03-28-2025
- Dividend Yield
- SANW N/A
- BRTX N/A
- EPS Growth
- SANW N/A
- BRTX N/A
- EPS
- SANW N/A
- BRTX N/A
- Revenue
- SANW $54,809,365.00
- BRTX $377,000.00
- Revenue This Year
- SANW N/A
- BRTX $482.76
- Revenue Next Year
- SANW $9.92
- BRTX $212.24
- P/E Ratio
- SANW N/A
- BRTX N/A
- Revenue Growth
- SANW N/A
- BRTX 189.55
- 52 Week Low
- SANW $2.10
- BRTX $1.03
- 52 Week High
- SANW $13.49
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- SANW 37.23
- BRTX 37.55
- Support Level
- SANW $7.10
- BRTX $2.26
- Resistance Level
- SANW $8.10
- BRTX $2.38
- Average True Range (ATR)
- SANW 0.65
- BRTX 0.22
- MACD
- SANW -0.25
- BRTX -0.09
- Stochastic Oscillator
- SANW 15.33
- BRTX 7.98
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.